Ruth Speidel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruth Speidel has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Abraham K. Badu-Tawiah
The Ohio State University
3 shared publications - Ayesha Seth
Department of Chemistry and Biochemistry, The Ohio State University, 100 West 18th Ave, Columbus, Ohio 43210, United States
2 shared publications - Ana Lucia Abreu-Silva
Universidade Estadual do Maranhão, Brasil
1 shared publication Hianka J. C. Carvalho
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio 43210, USA
1 shared publication- Hianka Jasmyne Costa de Carvalho
Department of Surgery, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo 05508-270, Brazil
1 shared publication - Hélida Monteiro de Andrade
Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-910, Belo Horizonte, Minas Gerais, Brazil
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (13) , 3803-3814
Differentiation of disaccharide isomers via diagnostic-ion-weighted spectral library searching using data from tandem MS analysis of chloride adducts
Chloride adducts of rare sugars enable diagnostic fragment ions to be generated in tandem MS, allowing a highly specific algorithm to be developed to differentiate isomers of rare sugars.
- 30 April 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (13) , 3803-3814
Open AccessDifferentiation of disaccharide isomers via diagnostic-ion-weighted spectral library searching using data from tandem MS analysis of chloride adducts
Chloride adducts of rare sugars enable diagnostic fragment ions to be generated in tandem MS, allowing a highly specific algorithm to be developed to differentiate isomers of rare sugars.
- Open Access
- 16 February 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (7) , 2077-2088
A paper-based immunoassay with signal amplification for the sensitive detection of nucleocapsid protein toward the diagnosis of long COVID
Long COVID is characterized by persistent symptoms, including fatigue, cognitive impairment, and respiratory issues, affecting a considerable number of individuals post-infection.
- 16 February 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (7) , 2077-2088
Open AccessA paper-based immunoassay with signal amplification for the sensitive detection of nucleocapsid protein toward the diagnosis of long COVID
Long COVID is characterized by persistent symptoms, including fatigue, cognitive impairment, and respiratory issues, affecting a considerable number of individuals post-infection.
- 24 March 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (13) , 7089-7097
A 2D Microfluidic Paper-Based Analytical Device for Diagnosis of Canine Visceral Leishmaniasis via Mass Spectrometry-Based Immunoassay
This work presents the first indirect immunoassay performed on a paper-based microfluidic platform for the diagnosis of canine visceral leishmaniasis (CVL). The IgG antibody biomarker, which signifies the presence of this infectious disease, was captured with a recombinant K39 antigen and detected with secondary antibodies that were conjugated with cleavable ionic probes. The use of ionic probes enabled direct analysis of the assay results through an on-chip paper spray mass spectrometry (MS) technology. This MS-based immunoassay was developed to allow for early detection of CVL in asymptomatic dogs. The sensitivity required for such a diagnostic method was demonstrated through internal standard calibration in which sample dilution as low as 1/4000 was achieved. Aside from high sensitivity, the ionic probes are stable, which allowed the paper device to be stored at room temperature and under ambient conditions for 30 days without affecting the diagnostic outcome. Our method was used to analyze 20 clinical canine serum samples, where we detected a 2 orders of magnitude higher signal for CVL-positive samples compared to negative samples. MS signal derived from the 10 CVL-positive serum clinical samples showed a strong correlation with antibody titers determined by immunofluorescence assay. This correlation was confirmed through Pearson's statistical analysis. Overall, the high sensitivity and positive results from stability tests observed for our platform are expected to enable large-scale CVL screening in asymptomatic dogs in remote areas, especially when combined with portable mass spectrometers.
- 24 March 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (13) , 7089-7097
A 2D Microfluidic Paper-Based Analytical Device for Diagnosis of Canine Visceral Leishmaniasis via Mass Spectrometry-Based Immunoassay
This work presents the first indirect immunoassay performed on a paper-based microfluidic platform for the diagnosis of canine visceral leishmaniasis (CVL). The IgG antibody biomarker, which signifies the presence of this infectious disease, was captured with a recombinant K39 antigen and detected with secondary antibodies that were conjugated with cleavable ionic probes. The use of ionic probes enabled direct analysis of the assay results through an on-chip paper spray mass spectrometry (MS) technology. This MS-based immunoassay was developed to allow for early detection of CVL in asymptomatic dogs. The sensitivity required for such a diagnostic method was demonstrated through internal standard calibration in which sample dilution as low as 1/4000 was achieved. Aside from high sensitivity, the ionic probes are stable, which allowed the paper device to be stored at room temperature and under ambient conditions for 30 days without affecting the diagnostic outcome. Our method was used to analyze 20 clinical canine serum samples, where we detected a 2 orders of magnitude higher signal for CVL-positive samples compared to negative samples. MS signal derived from the 10 CVL-positive serum clinical samples showed a strong correlation with antibody titers determined by immunofluorescence assay. This correlation was confirmed through Pearson's statistical analysis. Overall, the high sensitivity and positive results from stability tests observed for our platform are expected to enable large-scale CVL screening in asymptomatic dogs in remote areas, especially when combined with portable mass spectrometers.